PMID- 21306285 OWN - NLM STAT- MEDLINE DCOM- 20110701 LR - 20181201 IS - 1473-4877 (Electronic) IS - 0300-7995 (Linking) VI - 27 IP - 4 DP - 2011 Apr TI - Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial. PG - 821-33 LID - 10.1185/03007995.2011.555754 [doi] AB - OBJECTIVE: To investigate whether a proactive multifactorial risk factor intervention strategy using single-pill amlodipine/atorvastatin (5/10, 10/10 mg) in addition to other antihypertensive and lipid-lowering therapy, as required, resulted in greater reduction in calculated Framingham 10-year coronary heart disease (CHD) risk compared with usual care (UC) after 52-weeks treatment. RESEARCH DESIGN AND METHODS: Prospective, multinational, open-label, cluster randomized trial, with the investigator as the unit of randomization. Eligible hypertensive patients were 35-79 years of age, with >/=3 additional cardiovascular risk factors, but no history of CHD and baseline total cholesterol (TC)